60 Degrees Pharmaceuticals, Inc. (SXTP)
NASDAQ: SXTP · Real-Time Price · USD
1.740
-0.070 (-3.87%)
Apr 9, 2026, 4:00 PM EDT - Market closed
SXTP Revenue
In the year 2025, 60 Degrees Pharmaceuticals had annual revenue of $1.41M with 106.81% growth. 60 Degrees Pharmaceuticals had revenue of $316.38K in the quarter ending December 31, 2025, with 16.22% growth.
Revenue (ttm)
$1.41M
Revenue Growth
+106.81%
P/S Ratio
3.26
Revenue / Employee
$469,698
Employees
3
Market Cap
4.59M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.41M | 727.75K | 106.81% |
| Dec 31, 2024 | 681.35K | 427.77K | 168.70% |
| Dec 31, 2023 | 253.57K | -257.64K | -50.40% |
| Dec 31, 2022 | 511.21K | -5.84M | -91.95% |
| Dec 31, 2021 | 6.35M | 3.80M | 149.18% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Jaguar Health | 11.51M |
| Ensysce Biosciences | 5.07M |
| CollPlant Biotechnologies | 2.37M |
| AIM ImmunoTech | 88.00K |
| Pulmatrix | 3.00K |
SXTP News
- 9 days ago - 60 Degrees Pharmaceuticals Announces 2025 Annual Results - GlobeNewsWire
- 22 days ago - 60 Degrees Pharmaceuticals Files New Dietary Ingredient Notification (NDIN) with FDA for Australian Chestnut Extract - GlobeNewsWire
- 27 days ago - What's Going On With 60 Degrees Pharmaceuticals On Friday? - Benzinga
- 4 weeks ago - 60 Degrees Pharmaceuticals Announces All Patients Cured of Babesiosis After Tafenoquine Treatment in Expanded Use Clinical Trial - GlobeNewsWire
- 2 months ago - 60 Degrees Pharmaceuticals Expands Access to ARAKODA® with GoodRx Partnership - GlobeNewsWire
- 3 months ago - 60 Degrees Pharmaceuticals, Inc. Announces Approval of Reverse Stock Split Ratio - GlobeNewsWire
- 3 months ago - 60 Degrees Pharmaceuticals Announces Detection of Babesia Infection in 24 Percent of Patients Presenting with Chronic Fatigue in Peer-Reviewed, Sponsored Study at NC State - GlobeNewsWire
- 4 months ago - 60 Degrees Pharmaceuticals Announces Expansion of ARAKODA® Sales and Marketing in 2026 - GlobeNewsWire